小结
定义
病史和体格检查
关键诊断因素
- withdrawal
- tolerance
- increased/decreased liver size, jaundice, ascites
其他诊断因素
- insomnia
- erectile dysfunction
- nicotine use disorder
- gastrointestinal distress
- muscle cramps, pain, tenderness, altered sensory perception
- hypertension and tachycardia
- impaired nutritional status
- broad-based gait
危险因素
- family history of alcohol use disorder
- depression, anxiety, and other mental health disorders
- socioeconomic deprivation
- lack of facial flushing on exposure to alcohol
- low responsivity to the effects of alcohol
- history of gastric bypass
诊断性检查
首要检查
- diagnostic interview
- alcohol level (breath and blood)
- Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar)
需考虑的检查
- carbohydrate-deficient transferrin (CDT)
- gamma glutamyl transpeptidase (gamma-GT), alanine aminotransferase (ALT), aspartate aminotransferase (AST)
- CBC
- urinary ethyl glucuronide
- phosphatidylethanol (PEth)
治疗流程
at-risk drinking
alcohol use disorder: nonpregnant adult with no concurrent opioid use or mental health diagnosis
alcohol use disorder: nonpregnant adult with concurrent opioid use
alcohol use disorder: nonpregnant adult with concurrent mental health diagnosis
alcohol use disorder: nonpregnant adolescent
alcohol use disorder: pregnant
撰稿人
作者
Elisabeth Poorman, MD, MPH
Assistant Professor of Medicine
Department of Medicine
University of Illinois Chicago
Chicago
IL
利益声明
EP declares that she has no conflicting interests.
Marlene Martin, MD
Associate Professor of Clinical Medicine
Director, Addiction Care Team
San Francisco General Hospital
University of California, San Francisco
San Francisco
CA
利益声明
MM is a board member for the National Harm Reduction Coalition and has done consultancy work for the Society of Hospital Medicine.
Sarah Messmer, MD
Assistant Professor of Clinical Medicine and Pediatrics
University of Illinois Chicago
Chicago
IL
利益声明
SM declares that she has no conflicting interests.
鸣谢
Dr Elisabeth Poorman, Dr Marlene Martin, and Dr Sarah Messmer would like to gratefully acknowledge Dr Colin Drummond, Dr Julie R. Pittman, Dr Philip H. Chung, Dr Robert M. Swift, and Dr Lorenzo Leggio, previous contributors to this topic.
利益声明
CD, JRP, PHC, and RMS declare that they have no competing interests. LL is an author of a reference cited in this topic.
同行评议者
Stephen Holt, MD, MS
Associate Professor of Medicine
Yale School of Medicine
New Haven
CT
利益声明
SH declares that they have no competing interests.
Bhanu Prakash Kolla, MD, FRCPsych
Professor of Psychiatry
Department of Psychiatry and Psychology
Addiction Psychiatrist and Sleep Physician
Center for Sleep Medicine, Mayo Clinic
Rochester
MN
利益声明
BPK declares that they have no competing interests.
Paul S. Haber, MD
Royal Prince Alfred Hospital and Discipline of Medicine
University of Sydney
Sydney
Australia
利益声明
PSH is an author of a reference cited in this topic.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
参考文献
关键文献
American Society of Addiction Medicine. Engagement and retention of nonabstinent patients in substance use treatment: clinical consideration for addiction treatment providers. Oct 2024 [internet publication].全文
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
World Health Organization. International classification of diseases, 11th revision (ICD-11). Feb 2025 [internet publication].全文
US Department of Veterans Affairs. VA/DOD clinical practice guidelines: management of substance use disorders. 2021 [internet publication].全文
Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.全文 摘要
参考文献
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
鉴别诊断
- Other psychiatric disorders
- Other substance use disorders (especially sedatives)
更多 鉴别诊断指南
- Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR)
- Management of substance use disorders: guidelines from the VA/DoD
更多 指南患者教育信息
Alcohol-use disorder
更多 患者教育信息医学计算器
Alcohol Consumption Screening AUDIT Questionnaire
更多 医学计算器登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明